View Older Stories

Jan 12, 2026 10:10AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Goldman Sachs

Jan 12, 2026 08:07AM Harmony Biosciences forecasts WAKIX revenue to exceed $1 billion in 2026

Dec 16, 2025 06:30AM Beacon Biosignals partners with Harmony Biosciences for EEG sleep studies

Dec 8, 2025 08:05AM Harmony Biosciences shows seizure reduction in dravet syndrome trial

Dec 3, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

Dec 1, 2025 05:48AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $46 at Mizuho

Nov 25, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

Nov 24, 2025 08:06AM Harmony Biosciences reports positive pitolisant bioequivalence study results

Nov 24, 2025 04:40AM Oppenheimer Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY) Post Mgmt Meet

Nov 4, 2025 07:33AM Harmony Biosciences (HRMY) Tops Q3 EPS by 34c ; Offers Guidance

Oct 24, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

Oct 23, 2025 08:05AM Harmony Biosciences raises 2025 revenue guidance on strong WAKIX sales

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 15, 2025 06:17AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $43 at UBS

Sep 25, 2025 06:40AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $55 at H.C. Wainwright

Sep 25, 2025 06:11AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $35 at Mizuho

Sep 24, 2025 01:31PM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $62 at Oppenheimer

Sep 24, 2025 12:48PM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $50 at Cantor Fitzgerald

Sep 12, 2025 09:14AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $50 at UBS Ahead of Topline Data

Sep 9, 2025 02:39PM Harmony Biosciences (HRMY) 30-day option IV above 100

Sep 9, 2025 02:37PM Harmony Biosciences (HRMY) call put ratio 3.7 calls to 1 put as share price down 5.6%

Aug 11, 2025 06:28AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $50 at Mizuho

Aug 5, 2025 07:31AM Harmony Biosciences (HRMY) Tops Q2 EPS by 20c ; Offers Guidance

Jul 21, 2025 07:30AM Truist Securities Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy

Jul 21, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

Jul 10, 2025 06:28AM Goldman Sachs Resumes Harmony Biosciences Holdings Inc. (HRMY) at Neutral

Jul 7, 2025 06:24AM Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)

Jul 1, 2025 06:20AM Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)

Jun 23, 2025 06:37AM Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)

Jun 11, 2025 08:06AM Harmony Biosciences (HRMY) Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205

Jun 5, 2025 08:06AM Harmony Biosciences (HRMY) Announces Favorable Settlement in ANDA Litigation

Jun 2, 2025 08:52AM Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform

May 15, 2025 06:51AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $48 at Mizuho

May 6, 2025 07:31AM Harmony Biosciences (HRMY) Tops Q1 EPS by 42c, provides guidance

Apr 29, 2025 07:26AM H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

Apr 8, 2025 12:31PM Oppenheimer on Harmony Biosciences (HRMY): 'we remain pleased with WAKIX's 4Q24 performance'

Apr 8, 2025 08:05AM Harmony Biosciences (HRMY) Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome

Apr 3, 2025 08:05AM Harmony Biosciences (HRMY) Appoints Ron Philip to its Board

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 24, 2025 08:05AM Harmony Biosciences (HRMY) Appoints Adam Zaeske as Chief Commercial Officer

Mar 17, 2025 06:21AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $44 at Mizuho

Mar 13, 2025 06:58AM Cantor Biotech industry report, buying value in RevGens

Feb 27, 2025 06:59AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at H.C. Wainwright

Feb 26, 2025 09:37AM Cantor Fitzgerald Reiterates Overweight Rating on Harmony Biosciences Holdings Inc. (HRMY)

Feb 25, 2025 09:50AM Mizuho Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)

Feb 25, 2025 07:31AM Harmony Biosciences (HRMY) Tops Q4 EPS by 39c ; Offers Guidance

Feb 20, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)

Feb 20, 2025 06:11AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $42 at Mizuho

Feb 19, 2025 08:05AM Harmony Biosciences (HRMY) Provides Update on the Status of the Supplemental New Drug Application for Pitolisant

Feb 11, 2025 04:15AM Deutsche Bank Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy

View Older Stories